Voyager Therapeutics (VYGR) Share-based Compensation (2014 - 2026)
Voyager Therapeutics (VYGR) posted Share-based Compensation of $2.5 million for Q1 2026, down 29.34% sequentially from $3.5 million in Q4 2025, and down 32.26% YoY from $3.7 million in Q1 2025.
Voyager Therapeutics (VYGR) Share-based Compensation (2014 - 2026) Analysis & Trends
Voyager Therapeutics has reported Share-based Compensation for 13 years, with the latest figure at $2.5 million in Q1 2026.
- Quarterly Share-based Compensation fell 32.26% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.6 million (down 5.55% YoY) and the FY2025 annual result came in at $14.8 million, down 17.85% from the prior year.
- Share-based Compensation fell to $2.5 million in Q1 2026 per VYGR's latest filing, from $3.5 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $4.1 million in Q2 2025 and troughed at $2.1 million in Q3 2022.
- A 5-year average of $3.0 million and a median of $2.9 million in 2023 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 124.62% in 2022, down 36.45% in 2022.
- Over 5 years, Share-based Compensation stood at $2.2 million in 2022, then rose by 28.03% to $2.8 million in 2023, then increased by 23.74% to $3.4 million in 2024, then climbed by 3.13% to $3.5 million in 2025, then dropped by 29.34% to $2.5 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $2.5 million, $3.5 million, and $3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | - |
| 10 | Voyager Therapeutics | 205.56 Mn | 89.22 Mn | - | 2.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.43 Mn |
| Jun 30, 2026 | 2.43 Mn |
| Mar 31, 2026 | 2.49 Mn |
| Mar 31, 2026 | 2.49 Mn |
| Dec 31, 2025 | 3.52 Mn |
| Dec 31, 2025 | 3.52 Mn |
| Sep 30, 2025 | 3.46 Mn |
| Sep 30, 2025 | 3.46 Mn |
| Jun 30, 2025 | 4.13 Mn |
| Jun 30, 2025 | 4.13 Mn |
| Mar 31, 2025 | 3.67 Mn |
| Mar 31, 2025 | 3.67 Mn |
| Dec 31, 2024 | 3.41 Mn |
| Dec 31, 2024 | 3.41 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Jun 30, 2024 | 3.96 Mn |
| Jun 30, 2024 | 3.96 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Mar 31, 2024 | 3.50 Mn |